FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $42,527,968 | -83.7% | 4,214,863 | -63.8% | 0.37% | -79.7% |
| Q3 2022 | $261,207,000 | -1.4% | 11,655,833 | +1.6% | 1.82% | +16.2% |
| Q2 2022 | $265,041,000 | -37.8% | 11,473,655 | +4.4% | 1.57% | -11.9% |
| Q1 2022 | $426,012,000 | -29.4% | 10,988,182 | +6.6% | 1.78% | -2.5% |
| Q4 2021 | $603,365,000 | -6.6% | 10,312,167 | -5.4% | 1.82% | +17.5% |
| Q3 2021 | $646,177,000 | -0.5% | 10,902,258 | +45.7% | 1.55% | +28.4% |
| Q2 2021 | $649,458,000 | +20.2% | 7,483,102 | +14.2% | 1.21% | +12.7% |
| Q1 2021 | $540,422,000 | +104.8% | 6,554,546 | +125.9% | 1.07% | +52.8% |
| Q4 2020 | $263,852,000 | +358.4% | 2,901,700 | +101.5% | 0.70% | +105.9% |
| Q3 2020 | $57,556,000 | +64.5% | 1,439,970 | +41.2% | 0.34% | -9.3% |
| Q2 2020 | $34,990,000 | +183.8% | 1,019,830 | +83.7% | 0.38% | +22.5% |
| Q1 2020 | $12,328,000 | +46.1% | 555,082 | +28.8% | 0.31% | +44.1% |
| Q4 2019 | $8,437,000 | +60.2% | 431,128 | +27.2% | 0.21% | +85.2% |
| Q3 2019 | $5,265,000 | +16.8% | 339,039 | +52.7% | 0.12% | +0.9% |
| Q2 2019 | $4,508,000 | – | 222,064 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |